Stock market anomaly | China Biopharmaceuticals (01177.HK) rises by over 6% TRD205 "AT2R antagonist" has been included in the list of breakthrough therapeutic drugs by CDE.

According to the Zhongtong Finance APP, China Biopharmaceuticals (01177.HK) rose by more than 6%, as of the report, it rose by 6.07%, at 5.41 Hong Kong dollars, with a turnover of 452 million Hong Kong dollars.